Browsing by Author "Raghu, S.V."

Now showing 1 - 3 of 3

2,5-Bis(2,2,2-trifluoroethoxy)phenyl-tethered 1,3,4-Oxadiazoles Derivatives: Synthesis, In Silico Studies, and Biological Assessment as Potential Candidates for Anti-Cancer and Anti-Diabetic Agent
(MDPI, 2022) Shankara, S.D.; Isloor, A.M.; Kudva, A.K.; Raghu, S.V.; Jayaswamy, P.K.; Venugopal, P.P.; Shetty, P.; Chakraborty, D.
In the present work, a series of new 1-{5-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,3,4-oxadiazol-3-acetyl-2-aryl-2H/methyl derivatives were synthesized through a multistep reaction sequence. The compounds were synthesized by the condensation of various aldehydes and acetophenones with the laboratory-synthesized acid hydrazide, which afforded the Schiff’s bases. Cyclization of the Schiff bases yielded 1,3,4-oxadiazole derivatives. By spectral analysis, the structures of the newly synthesized compounds were elucidated, and further, their anti-cancer and anti-diabetic properties were investigated. To examine the dynamic behavior of the candidates at the binding site of the protein, molecular docking experiments on the synthesized compounds were performed, followed by a molecular dynamic simulation. ADMET (chemical absorption, distribution, metabolism, excretion, and toxicity) prediction revealed that most of the synthesized compounds follow Lipinski’s rule of 5. The results were further correlated with biological studies. Using a cytotoxic assay, the newly synthesized 1,3,4-Oxadiazoles were screened for their in vitro cytotoxic efficacy against the LN229 Glioblastoma cell line. From the cytotoxic assay, the compounds 5b, 5d, and 5m were taken for colony formation assay and tunnel assay have shown significant cell apoptosis by damaging the DNA of cancer cells. The in vivo studies using a genetically modified diabetic model, Drosophila melanogaster, indicated that compounds 5d and 5f have better anti-diabetic activity among the different synthesized compounds. These compounds lowered the glucose levels significantly in the tested model. © 2022 by the authors.
An iron(iii) oxide-anchored conductive polymer-graphene ternary nanocomposite decorated disposable paper electrode for non-enzymatic detection of serotonin
(Royal Society of Chemistry, 2024) Prashanth, S.; Aziz, R.A.; Raghu, S.V.; Shim, Y.-B.; Prasad, K.; Vasudeva Adhikari, A.V.
Serotonin, also known as 5-hydroxytryptamine (5-HT), is an important neurotransmitter that regulates many physiological processes. Both low and high concentrations of 5-HT in the body are associated with several neurological disorders. Hence, there is an urgent need to develop fast, accurate, reliable, and cost-effective disposable sensors for 5-HT detection. Herein, we report the sensing of 5-HT using a disposable paper-based electrode (PPE) modified with a ternary nanocomposite comprising poly(pyrrole) (P(py)), reduced graphene oxide (rGO), and iron oxide (Fe2O3). The sensor material was well characterized in terms of its structural, morphological, and chemical attributes using electron microscopy, spectral techniques, and electrochemical studies to prove the robust formation of the electroactive ternary nanocomposite and its suitability for 5-HT detection. The developed sensor exhibited an impressive limit of detection (LOD) of 22 nM with a wide linear range of 0.01 to 500 ?M, which falls in the recommended clinically relevant range. The analytical recovery, spike sample analysis, and interference studies with ascorbic acid (AA), uric acid (UA), and epinephrine (E) showed satisfactory results, wherein the sensor could detect simultaneously both 5-HT and dopamine (DA). The potential practical utility of the developed sensor was further assessed by quantifying the concentration of 5-HT in the brain samples of Drosophila melanogaster, a versatile genetic model organism employed for modeling different neural disorders in humans, and validated by gold-standard HPLC-UV experiments. The as-fabricated single-run disposable sensor with a ternary nanocomposite exhibits excellent stability with good reproducibility and is a promising platform for identifying clinically relevant concentrations of 5-HT. © 2024 RSC.
Conductive nano nickel oxide/hydroxide paper electrochemical sensor for serotonin detection in genetically engineered Drosophila
(Royal Society of Chemistry, 2025) Prashanth, S.; Kadandelu, M.; Raghu, S.V.; Prasad, K.S.; Vasudeva Adhikari, A.V.
Serotonin is considered an integral part in neuropsychiatric diseases, such as major depressive disorder, schizophrenia, post-traumatic stress disorder, obsessive-compulsive disorder, anxiety disorder, and substance use disorder. Understanding the levels of serotonin under different disease conditions is important. Herein, we explored the development of an efficient electrochemical sensor utilizing sustainable paper electrode integrated with nanocomposites through a simultaneous electrochemical deposition strategy. The as-developed sensor is further investigated with surface and electrochemical studies to understand the robust fabrication of the sensor as well as the electrochemical characteristics to show the improved electron transfer kinetics and detection capabilities even in the presence of common interfering biomolecules. The sensor demonstrated a broad linear range from 0.007 nM to 500 ?M, with an impressive limit of detection of 0.024 nM for the low concentration range (0.007-0.48 nM) and 383.7 nM for the high concentration range both falling well within the clinically relevant detection levels of serotonin. To evaluate the practical performance, the developed sensor was tested on brain homogenates obtained from genetically modified Drosophila melanogaster models with different serotonin levels. The sensor effectively detected the in vivo changes in serotonin level, and the results were validated against gold-standard HPLC analysis and immunohistochemical staining experiments. The sensors’ notable stability, selectivity, and sensitivity towards serotonin make them a valuable tool for neurochemical research and clinical applications, particularly in studying serotonin-related neurological conditions and advancing personalized treatments. © 2025 The Royal Society of Chemistry.